financetom
Business
financetom
/
Business
/
Cencora Insider Sold Shares Worth $1,296,822, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cencora Insider Sold Shares Worth $1,296,822, According to a Recent SEC Filing
Mar 20, 2025 1:24 AM

04:12 AM EDT, 03/20/2025 (MT Newswires) -- Robert P. Mauch, Director, President & Chief Executive Officer, on March 18, 2025, sold 4,970 shares in Cencora ( COR ) for $1,296,822. Following the Form 4 filing with the SEC, Mauch has control over a total of 49,326 common shares of the company, with 49,326 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1140859/000114085925000061/xslF345X05/wk-form4_1742416710.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Merck to Discontinue Zinplava for Clostridioides Difficile Infection
Market Chatter: Merck to Discontinue Zinplava for Clostridioides Difficile Infection
Dec 24, 2024
06:12 AM EST, 12/24/2024 (MT Newswires) -- Merck ( MRK ) will discontinue its antibody drug, Zinplava, which was approved in 2016 to prevent the recurrence of Clostridioides difficile infections, Reuters reported late Monday, citing the US Food and Drug Administration. Clostridioides difficile infections, often caused by prolonged antibiotic use, can lead to severe diarrhea and colon inflammation. The report...
AstraZeneca, Daiichi Sankyo Withdraw EU Marketing Application for Lung Cancer Drug Candidate
AstraZeneca, Daiichi Sankyo Withdraw EU Marketing Application for Lung Cancer Drug Candidate
Dec 24, 2024
05:59 AM EST, 12/24/2024 (MT Newswires) -- AstraZeneca ( AZN ) and Daiichi Sankyo said Tuesday they have voluntarily withdrawn their marketing authorization application in the European Union for datopotamab deruxtecan, which was intended to treat advanced or metastatic non-squamous non-small cell lung cancer. The companies said the decision follows feedback from the European Medicines Agency's Committee for Medicinal Products...
BlackRock Municipal Income Fund to Convert Into Unlisted Interval Fund
BlackRock Municipal Income Fund to Convert Into Unlisted Interval Fund
Dec 24, 2024
06:24 AM EST, 12/24/2024 (MT Newswires) -- BlackRock Municipal Income Fund ( MUI ) said late Monday it is planning to convert from an exchange-listed closed-end fund to an unlisted, continuously-offered closed-end fund called BlackRock Municipal Credit Alpha Portfolio. The company said the conversion is expected to occur after market close on March 21, with an effective date of March...
Golar LNG Takes Full Ownership of FLNG Hilli
Golar LNG Takes Full Ownership of FLNG Hilli
Dec 24, 2024
06:01 AM EST, 12/24/2024 (MT Newswires) -- Golar LNG (GLNG) said Tuesday it acquired all outstanding minority interests in the FLNG Hilli from Seatrium and Black & Veatch for a total of $90.2 million, taking full ownership of the liquefied natural gas vessel. The total consideration comprises $59.9 million in equity and $30.3 million of a pro-rata share in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved